Axsome Therapeutics, Inc

1. 01

   Behind SPY and its sector fund XLV over 1 year

   1 month: −21.4% (SPY −1.6%, XLV +13.5%). 3 months: −35.6% (SPY −0.4%, XLV +15.5%). 1 year: +1.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: AXSM, SPY and XLV · as of 4 Nov 2026

2. 02

   Below its 50- and 200-day averages

   The 4 Nov 2026 close of $137.00 was 24.2% below its 50-day average ($180.64) and 31.1% below its 200-day average ($198.71). It has closed below the 200-day for 31 sessions, since 23 Sep 2026. The 50-day average crossed below the 200-day on 14 Oct 2026, 15 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

3. 03

   11.4% above its 52-week low

   Closed at $137.00 on 4 Nov 2026: 47.3% below the 52-week high of $260.19 (18 Jun 2026) and 11.4% above the low of $123.00 (2 Nov 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

4. 04

   Volume 2.9× its 30-session average on 2 Nov 2026

   2 Nov 2026 volume of 2.7M shares was 2.9× the average of the 30 sessions before it (924.1K), as the price fell 5.8%. SPY traded 1.2× its own average that session.

   Daily volume against a 30-session baseline · as of 2 Nov 2026

5. 05

   RSI(14) at 24.6, 30 or below

   The 14-session relative strength index closed at 24.6 on 4 Nov 2026, its 24th session at 30 or below. By convention a reading of 30 or below is called oversold and 70 or above overbought.

   Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

At the 4 Nov 2026 close